Strategies for robust process characterization and validation to accelerate biologics manufacturing

Webinar on demand

Establishing strong process characterization and validation early is critical to ensuring biologics are developed efficiently, in compliance, and ready for scale—but these steps are often underestimated and overlooked until late in development.

In this webinar, experts from Thermo Fisher Scientific will share real-world examples that uncover commonly overlooked steps and how to create a robust, data-driven process design to help accelerate validation readiness and reduce manufacturing risk.

Together, we will learn how partnering with a CDMO early and an integrated approach to process understanding can help you move faster from development to commercial success.

Key takeaways include:

  • A toolbox of strategies for an efficient technology transfer
  • Design and execution of robust process characterization and validation
  • Data-driven validation approaches for early-phase development and commercial manufacturing

Helpful resources

Preparing your biologic for commercialization: strategies to reduce risk and optimize outcomes
Watch this expert roundtable discussion highlighting new technologies and strategies to reduce risk and execute consistently when developing and commercializing biopharmaceutical products.
Webinar
Scaling smart: Overcoming the top roadblocks in biologic drug manufacturing
This on-demand webinar explores how a unified, global CDMO model can help biologic drug developers overcome the most pressing challenges in clinical and commercial manufacturing.
Advance Biologics from Final DNA to Phase I in Under 9 Months
Explore how our novel Path to IND platform helps biotech companies move from DNA to first-in-human Phase I clinical trials in as little as nine months.